Inhibition of D-Amino Acid Oxidase Activity by Antipsychotic Drugs Evaluated by a Fluorometric Assay Using D-Kynurenine as Substrate

被引：14

作者：

Iwasa, Sumiko ^{[1
]}

Tabara, Hiroshi ^{[1
]}

Song, Ziyu ^{[1
]}

Nakabayashi, Moe ^{[1
]}

Yokoyama, Yuusaku ^{[2
]}

Fukushima, Takeshi ^{[1
]}

机构：

[1] Toho Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Chiba 2748510, Japan

[2] Toho Univ, Dept Synthet Organ Chem, Fac Pharmaceut Sci, Chiba 2748510, Japan

来源：

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2011年 / 131卷 / 07期

基金：

日本学术振兴会;

关键词：

D-amino acid oxidase; antipsychotic drug; fluorescence; D-kynurenine; RECEPTOR HYPOFUNCTION HYPOTHESIS; D-SERINE; IN-VITRO; SCHIZOPHRENIA; CHLORPROMAZINE; BRAIN; DAAO; NEUROTRANSMISSION; DISCOVERY; RACEMASE;

D O I：

10.1248/yakushi.131.1111

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A facile fluorometric assay using D-kynurenine as a substrate was utilized for evaluating the inhibition of D-amino acid oxidase (DAAO), which is one of the products of a susceptibility gene for schizophrenia, by commercial antipsychotic drugs, namely, chlorpromazine (CPZ), carbamazepine, sulpiride, quetiapine, and imipramine. CPZ inhibited DAAO (65.8 +/- 13.2 mu M, n=3) as reported previously, and other drugs also inhibited DAAO activity. Among these, quetiapine had the smallest IC50 value (19.5 +/- 2.60 mu M, n=3). The proposed assay can be useful for the evaluation or screening of DAAO-inhibitory drugs.

引用

页码：1111 / 1116

页数：6

共 50 条

[21] Characterization of human D-amino acid oxidase
Molla, G
Sacchi, S
Bernasconi, M
Pilone, MS
Fukui, K
Pollegioni, L
FEBS LETTERS, 2006, 580 (09): : 2358 - 2364
[22] Substrate recognition and activation mechanism of D-amino acid oxidase: A study using substrate analogs
Nishina, Y
Sato, K
Miura, R
Shiga, K
JOURNAL OF BIOCHEMISTRY, 2000, 128 (02) : 213 - 223
[23] Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
Lin, Chieh-Hsin
Yang, Hui-Ting
Chiu, Chih-Chiang
Lane, Hsien-Yuan
SCIENTIFIC REPORTS, 2017, 7
[24] An association study of D-amino acid oxidase and D-amino acid oxidase activator polymorphisms and schizophrenia in patients from Turkey
Kartalci, Sukru
Acar, Ceren
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2016, 17 (05): : 341 - 346
[25] D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
Sacchi, Silvia
Rosini, Elena
Pollegioni, Loredano
Molla, Gianluca
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (14) : 2499 - 2511
[26] Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Madeira, Caroline
Freitas, Maria Eliza
Vargas-Lopes, Charles
Wolosker, Herman
Panizzutti, Rogrio
SCHIZOPHRENIA RESEARCH, 2008, 101 (1-3) : 76 - 83
[27] D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity
Yamanaka, Masahiro
Miyoshi, Yurika
Ohide, Hiroko
Hamase, Kenji
Konno, Ryuichi
AMINO ACIDS, 2012, 43 (05) : 1811 - 1821
[28] Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment
Caldinelli, Laura
Molla, Gianluca
Bracci, Luisa
Lelli, Barbara
Pileri, Silvia
Cappelletti, Pamela
Sacchi, Silvia
Pollegioni, Loredano
PROTEIN SCIENCE, 2010, 19 (08) : 1500 - 1512
[29] The C-Terminal Region of G72 Increases d-Amino Acid Oxidase Activity
Chang, Sunny Li-Yun
Hsieh, Chia-Hung
Chen, Yen-Ju
Wang, Chien-Ming
Shih, Chung-Shiuan
Huang, Pei-Wen
Mir, Asif
Lane, Hsien-Yuan
Tsai, Guochuan E.
Chang, Hao-Teng
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (01): : 29 - 43
[30] Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity
Zhang, Min
Ballard, Michael E.
Basso, Ana M.
Bratcher, Natalie
Browman, Kaitlin E.
Curzon, Pete
Konno, Ryuichi
Meyer, Axel H.
Rueter, Lynne E.
BEHAVIOURAL BRAIN RESEARCH, 2011, 217 (01) : 81 - 87

← 1 2 3 4 5 →